Cargando…

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high morbidity and mortality. Therefore, it is very important to find potential biomarkers that can effectively predict the prognosis and progression of HCC. Recent studies have shown that anti-silencing function 1B (ASF1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Xiaoxi, Lv, Longxian, Zhao, Yalei, Zhang, Fen, Hu, Qingqing, Li, Zuhong, Zhu, Danhua, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787347/ https://www.ncbi.nlm.nih.gov/pubmed/35087760 http://dx.doi.org/10.3389/fonc.2021.801506

Ejemplares similares

Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways
por: Li, Zuhong, et al.
Publicado: (2017)

A promising new cancer marker: Long noncoding RNA EGFR-AS1
por: Zhu, Danhua, et al.
Publicado: (2023)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment
por: Li, Zuhong, et al.
Publicado: (2019)

Multi-Omic Analyses of the m(5)C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma
por: Zhao, Yalei, et al.
Publicado: (2020)

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
por: Zhang, Wencheng, et al.
Publicado: (2021)

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer
por: Lu, Juan, et al.
Publicado: (2022)

The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma
por: Zhang, Zifa, et al.
Publicado: (2023)

SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma
por: Hu, Qingqing, et al.
Publicado: (2022)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
por: Tian, Guo, et al.
Publicado: (2018)

Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis
por: Yang, Ya, et al.
Publicado: (2022)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

Research priorities to fill knowledge gaps on ASF seasonality that could improve the control of ASF
por: Nielsen, Søren Saxmose, et al.
Publicado: (2021)

TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer
por: Li, Zhigui, et al.
Publicado: (2023)

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
por: Cai, Lin, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment
por: Ma, Jing, et al.
Publicado: (2021)

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
por: Wen, Jie, et al.
Publicado: (2022)

African Swine Fever (ASF) and Ticks. No Risk of Tick-mediated ASF Spread in Poland and Baltic States
por: Frant, Maciej, et al.
Publicado: (2017)

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
por: Wen, Jie, et al.
Publicado: (2022)

ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer
por: Chen, Chuanzhi, et al.
Publicado: (2022)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma
por: Zhao, Junsheng, et al.
Publicado: (2021)

SPR-Based Detection of ASF Virus in Cells
por: Capo, Alessandro, et al.
Publicado: (2022)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas
por: Zhang, Xiaoyang, et al.
Publicado: (2022)

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy
por: Zhang, Lingjian, et al.
Publicado: (2019)

A prognostic model for hepatitis B acute‐on‐chronic liver failure patients treated using a plasma exchange‐centered liver support system
por: Xie, Zhongyang, et al.
Publicado: (2019)

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma
por: Chu, Yu-De, et al.
Publicado: (2022)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice
por: Wang, Xuemei, et al.
Publicado: (2021)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway
por: Zhang, Zao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_60cvg9k8amh3quka00g6qi2ljl